Is cycle network expansion cost-effective? A health economic evaluation of cycling in Oslo

BMC Public Health

Table 2 Relative risk of incidence and mortality for the disease states

Disease	Base value	Lower	Upper	Distribution	Source
Disease	RR of mortality^a
CHD	3.89	3.81	3.97	Lognormal	[29]
Stroke	3.89	3.81	3.97	Lognormal	[29]
T2D	2.61	2.34	2.88	Lognormal	[30]
Cancer	4.20	4.00	4.30	lognormal	[31]
	Relative risk for disease (Active vs inactive)
Cancer	0.55	0.36	0.84	Lognormal	[32]
CHD	0.80	0.75	0.86	Lognormal	[33]
Stroke	0.82	0.77	0.87	Lognormal	[33]
T2D	0.74	0.72	0.77	Lognormal	[33]

^aRelative risks (RRs) of CVD mortality except for cancer (which is RR of all-cause mortality)

ISSN: 1471-2458